ZA200306283B - Alkoxycarbonylamino heteroaryl carboxylic acid derivatives as IP antagonists. - Google Patents

Alkoxycarbonylamino heteroaryl carboxylic acid derivatives as IP antagonists.

Info

Publication number
ZA200306283B
ZA200306283B ZA200306283A ZA200306283A ZA200306283B ZA 200306283 B ZA200306283 B ZA 200306283B ZA 200306283 A ZA200306283 A ZA 200306283A ZA 200306283 A ZA200306283 A ZA 200306283A ZA 200306283 B ZA200306283 B ZA 200306283B
Authority
ZA
South Africa
Prior art keywords
alkoxycarbonylamino
antagonists
carboxylic acid
acid derivatives
heteroaryl carboxylic
Prior art date
Application number
ZA200306283A
Other languages
English (en)
Inventor
Lopez-Tapia Francisco J Counde
Dov Nitzan
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of ZA200306283B publication Critical patent/ZA200306283B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA200306283A 2001-03-02 2003-08-13 Alkoxycarbonylamino heteroaryl carboxylic acid derivatives as IP antagonists. ZA200306283B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27284901P 2001-03-02 2001-03-02

Publications (1)

Publication Number Publication Date
ZA200306283B true ZA200306283B (en) 2004-11-15

Family

ID=23041569

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200306283A ZA200306283B (en) 2001-03-02 2003-08-13 Alkoxycarbonylamino heteroaryl carboxylic acid derivatives as IP antagonists.

Country Status (14)

Country Link
US (1) US6569860B2 (ko)
EP (1) EP1368345B1 (ko)
JP (1) JP2004526721A (ko)
KR (1) KR100589990B1 (ko)
CN (1) CN1280289C (ko)
AR (1) AR033429A1 (ko)
AT (1) ATE321041T1 (ko)
BR (1) BR0207730A (ko)
CA (1) CA2438813C (ko)
DE (1) DE60210058T2 (ko)
ES (1) ES2260425T3 (ko)
MX (1) MXPA03007864A (ko)
WO (1) WO2002070514A1 (ko)
ZA (1) ZA200306283B (ko)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040054008A1 (en) 2002-09-13 2004-03-18 Tohru Araki Medicament for treatment of nocturia
US20060171945A1 (en) * 2003-02-14 2006-08-03 Critchley Hilary Octavia D Ip receptor antagonists for the treatment of pathological uterine conditions
KR100840114B1 (ko) * 2005-10-20 2008-06-19 주식회사 엘지화학 점착제 조성물
WO2007046646A1 (en) * 2005-10-20 2007-04-26 Lg Chem, Ltd. Novel organic silane compound
AR069650A1 (es) * 2007-12-14 2010-02-10 Actelion Pharmaceuticals Ltd Derivados de aminopirazol como agonistas no peptidicos del receptor alx humano
WO2014143591A1 (en) 2013-03-12 2014-09-18 Allergan, Inc. Inhibition of neovascularization by simultaneous inhibition of prostanoid ip and ep4 receptors
WO2014143592A1 (en) 2013-03-12 2014-09-18 Allergan, Inc. Inhibition of neovascularization by inhibition of prostanoid ip receptors
PL3762368T3 (pl) 2018-03-08 2022-06-06 Incyte Corporation ZWIĄZKI AMINOPIRAZYNODIOLOWE JAKO INHIBITORY PI3K-γ
WO2020010003A1 (en) 2018-07-02 2020-01-09 Incyte Corporation AMINOPYRAZINE DERIVATIVES AS PI3K-γ INHIBITORS
EP4119138A1 (en) * 2021-07-12 2023-01-18 Universität Hamburg Dhodh inhibitors and their use as antiviral agents

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5908842A (en) 1995-12-08 1999-06-01 Merck & Co., Inc. Substituted 2-acylamino-pyridines as inhibitors of nitric oxide synthase
US6184242B1 (en) 1997-09-04 2001-02-06 Syntex Usa (Llc) 2-(substituted-phenyl)amino-imidazoline derivatives
AU1176299A (en) * 1997-11-26 1999-06-15 Yoshitomi Pharmaceutical Industries, Ltd. Tryptase inhibitors comprising heterocyclic amide compounds
CN1173950C (zh) * 1998-10-06 2004-11-03 大日本制药株式会社 2,3-二取代的吡啶衍生物、其制备方法、含有其的药物组合物和用于制备中的中间体
US6335459B1 (en) * 1998-12-23 2002-01-01 Syntex (U.S.A.) Llc Aryl carboxylic acid and aryl tetrazole derivatives as IP receptor modulators
EE200200065A (et) * 1999-08-12 2003-04-15 Pharmacia Italia S.P.A. 3-aminopürasooli derivaadid, nende valmistamine ja kasutamine vähivastaste toimeainetena ning neid sisaldav farmatseutiline kompositsioon
PL207869B1 (pl) 2000-03-16 2011-02-28 Hoffmann La Roche Pochodne kwasu karboksylowego, środek farmaceutyczny i sposób wytwarzania pochodnych kwasu karboksylowego

Also Published As

Publication number Publication date
ATE321041T1 (de) 2006-04-15
US20020169171A1 (en) 2002-11-14
CN1494544A (zh) 2004-05-05
JP2004526721A (ja) 2004-09-02
KR100589990B1 (ko) 2006-06-15
BR0207730A (pt) 2004-03-23
WO2002070514A1 (en) 2002-09-12
DE60210058D1 (de) 2006-05-11
EP1368345B1 (en) 2006-03-22
CN1280289C (zh) 2006-10-18
US6569860B2 (en) 2003-05-27
KR20030078962A (ko) 2003-10-08
EP1368345A1 (en) 2003-12-10
ES2260425T3 (es) 2006-11-01
MXPA03007864A (es) 2003-12-04
CA2438813C (en) 2008-07-29
AR033429A1 (es) 2003-12-17
CA2438813A1 (en) 2002-09-12
DE60210058T2 (de) 2006-11-09

Similar Documents

Publication Publication Date Title
HK1054924A1 (en) Carboxylic acid derivatives as ip antagonists
MXPA03009565A (es) Derivado de acido carboxilico y una sal del mismo.
HK1074176A1 (en) Quinoline derivatives as neuropeptide y antagonists
AU2002349021A1 (en) Heteroaryl carboxylic acid amides
IL175349A0 (en) 2-halogen-6-alkyl-phenyl substituted tetramic acid derivatives
PL372295A1 (en) Quinoline derivatives as npy antagonists
MXPA03007310A (es) Derivados de ftalazinona piperidino como inhibidores pde4.
MXPA02008402A (es) Derivados de quinolina como antagonistas alfa-2.
AU2002366320A1 (en) Lactams as tachykinin antagonists
AU2002222552A1 (en) Substituted carboxylic acid derivatives
MXPA03008140A (es) Amidas de acido benzofuran-2-carboxilico sustituidas.
AU2002222574A1 (en) Substituted carboxylic acid derivatives
ZA200306283B (en) Alkoxycarbonylamino heteroaryl carboxylic acid derivatives as IP antagonists.
MXPA03007865A (es) Derivados de acido alcoxicarbonilamino benzoico y alcoxicarbonilamino tetrazolil fenilo como antagonistas ip.
AU2002226356A1 (en) Quinoline derivatives as nk-3 antagonists
AU2002222573A1 (en) Substituted carboxylic acid derivatives
PL378119A1 (pl) Kwasy karboksylowe
AU2002222550A1 (en) Substituted carboxylic acid derivatives
EG23429A (en) Novel a-oxygenated or a-thiolated carboxylic acid phenethylamide derivatives.
AU2002222549A1 (en) Substituted carboxylic acid derivatives
AU2003286316A1 (en) 5-aminophenanthridine derivatives as npy-5 antagonists
NO20042664L (no) Karboksylsyrederivat
AU2002222551A1 (en) Substituted carboxylic acid derivatives
ATE468321T1 (de) Neue alpha-oxidierte carbonsäure-phenethylamid- derivate
ZA200306073B (en) Alkoxycarbonylamino benzoic acid or alkoxycarbonylamino tetrazolyl phenyl derivatives as IP antagonists.